Antimicrobial Resistance of Escherichia coli Causing Uncomplicated Urinary Tract Infections: A European Update for 2014 and Comparison with 2000 and 2008

Infectious Diseases and Therapy

Volumn 4, Issue 4, 2015, Pages 417-423

  Kahlmeter, Gunnar ^a   Åhman, Jenny ^a   Matuschek, Erika ^a  

^a CENTRAL HOSPITAL   (Sweden)

Author keywords

Amoxicillin clavulanic acid; Antimicrobial resistance; Cefadroxil; Ciprofloxacin; Escherichia coli; Mecillinam; Nitrofurantoin; Susceptibility; Trimethoprim; Urinary isolates; Urinary tract infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFADROXIL; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; MECILLINAM; NITROFURANTOIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; FRANCE; GERMANY; HUMAN; NONHUMAN; PRIORITY JOURNAL; SPAIN; UNITED KINGDOM; URINARY TRACT INFECTION;

EID: 84977123359     PISSN: 21938229     EISSN: 21936382     Source Type: Journal    
DOI: 10.1007/s40121-015-0095-5     Document Type: Article

References (18)

1. Allocati N, Masulli M, Alexeyev MF, Di Ilio C. Escherichia coli in Europe: an overview. Int J Environ Res Public Health. 2013;10:6235–54.
2. The Microbial Threat. Copenhagen: Invitational EU Conference, Denmark, September 1998 (Workshops 7–8 September).
3. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from acute uncomplicated urinary tract infections: the ECO.SENS project. J Antimicrob Chemother. 2003;51:69–76.
4. Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited. Int J Antimicrob Agents. 2012;39:45–51.
5. The European Committee on Antimicrobial Susceptibility Testing. EUCAST Disk Diffusion Test Manual. v 4.0; 2014. http://www.eucast.org.
6. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0; 2014. http://www.eucast.org.
7. The Swedish Reference Group for Antibiotics (SRGA) and its subcommittee on antibiotics (SRGA-M). http://www.srga.org.
8. Lobet B, Valot A, Cattoir V, et al. Comparison of antimicrobial susceptibility of 1217 Escherichia coli isolates from women with hospital and community acquired urinary tract infections (Article in French). Presse Med. 2008;37:46–50.
9. Neuzillet V, Naber KG, Schito G, et al. French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for therapy. Med Mal Infect. 2012;42:66–75.
10. Kresken M, Pfeifer Y, Hafner D, et al. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum beta-lactamases and the role of fosfomycin. Int J Antimicrob Agents. 2014;44:295–300.
11. Schmiemann G, Gagyor I, Hummers-Pradier E, et al. Resistance profiles of urinary tract pathogens in general practice—an observational study. BMC Urol. 2012;21–33.
12. Garcia Garcia ML, Munoz Bellido JL, Garcia Rodriguez JA, et al. In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in Spain: a comparative multicenter study (2002–2004). J Chemother. 2007;19:263–70.
13. Gobernado M, Valdes L, Alos JI, et al. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimoter. 2007;20:68–76.
14. Lindback H, Lindback J, Sylvan S, Melhus A. Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTS-M-15 in Uppsala County. Scand J Infect Dis. 2010;42:243–8.
15. Bean DC, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005–2006. Ann Clin Microbiol Antimicrob. 2008;7:13.
16. Schito GC, Naber KG, Botto H, et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34:407–13.
17. Poulsen HO, Johansson A, Granholm S, Kahlmeter G, Sundqvist M. High genetic diversity of nitrofurantoin or mecillinam resistant Escherichia coli indicates low propensity for clonal spread. J Antimicrob Chemother. 2013;68:1974–7.
18. Theuretzbacher U, Van Bambeke F, Canton R, et al. Reviving old antibiotics. J Antimicrob Chemother. 2015;70(8):2177–81.